NANETTE VELA: Open Payments
NPI 1194230714 · RIO RANCHO, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,039 in 28 payments from 9 companies in 2025. Trend: 2023 $202 · 2024 $225 · 2025 $1,039
Food & beverage: $1,039
| Company | Payments | Amount |
|---|---|---|
| Philips North America LLC | 12 | $538 |
| AstraZeneca Pharmaceuticals LP | 2 | $142 |
| Novo Nordisk Inc | 2 | $129 |
| Merck Sharp & Dohme LLC | 3 | $66 |
| ABIOMED | 2 | $55 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 4 | $49 |
| Lilly USA, LLC | 1 | $21 |
| Medtronic, Inc. | 1 | $19 |
| Amgen Inc. | 1 | $19 |
Products named: Ambulatory Monitoring & Diagnostics Undivided, FARXIGA, Wegovy, VERQUVO, LifeVest, MOUNJARO, LINQ II, REPATHA.
Industry payments across NM — which companies pay providers there.
